CD8A and cholangitis: Moreover, owed to the ability of LSECs to cross-present peptides that were delivered with LSEC-targeting nanoparticles, this approach could also be used to induce antigen-specific CD8 T cell tolerance and protection from CD8 T cell–mediated cholangitis [61].